DNA ploidy, p53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi

Anticancer Research

Volumn 16, Issue 1, 1996, Pages 201-208

  Itakura, Yuko ^a   Sasano, Fhironobu ^a   Date, Fumiko ^a   Kato, Katsuaki ^a   Sekine, Hitoshi ^a   Mori, Shozo ^a   Nagura, Hiroshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DNA ploidy; Esophagus; Ki67; P53

Indexed keywords

CELL DNA; MONOCLONAL ANTIBODY KI 67; PROTEIN P53;

ADULT; AGED; ARTICLE; BIOPSY; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL FEATURE; CONTROLLED STUDY; DYSPLASIA; ESOPHAGITIS; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; DNA, NEOPLASM; EPITHELIAL CELLS; EPITHELIUM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PLOIDIES; PRECANCEROUS CONDITIONS; S PHASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029871878     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Yang CS: Research onoesophageal cancer in China: a review. Cancer Res 40: 2633-2644, 1980.
2. Wang LD, Hong JY, Qiu SL, Gao H and Yang CS: Accumulation of p53 protein in human oesophageal precancerous lesions: A possible early biomarker for carcinogenesis. Cancer Res 53. 1783-1787, 1993.
3. Jaskiewicz K and De Groot KM: p53 gene mutants expression, cellular proliferation and differentiation in oesophageal carcinoma and non-cancerous epithelium. Anticancer Res 14: 137-140, 1994.
4. Itakura Y, Sasano H, Mori S and Nagura H: DNA ploidy in human esophageal squamous dysplasias and squamous cell carcinomas as determined by image analysis. Modern Pathology 8: 867-873, 1994.
5. Shin DM, Kim J, Ro JY, Hittelman J, Roth JA, Hong WK and Hittelman WN: Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54. 321-326, 1994.
6. Qiu S and Yang G. Precursor lesions of oesophageal cancer in high-risk populations in Henan province, China. Cancerx 62: 551-557, 1988.
7. Ohta H, Nakazawa S, Segawa K and Yoshino J: Distribution of epithelial dysplasia in the cancerous oesophagus. Scand J Gastroenterol 21 392-398, 1986
8. Muoz N, Crespi M, Grassi A, Qing WG, Qiong S and Cai LZ: Precursor lesions of oesophageal cancer in high-risk populations in Iran and China. Lancet i: 876-879, 1982.
9. Jacob P, Kahrilas PJ, Desai T, Hidvegi D, Walloch J, Yokoo H, Gurley AM and Ostrow JD: Natural history and significance of oesophageal squamous cell dysplasia. Cancer 65: 2731-2739, 1990.
10. Jaskiewicz K, Venter FS and Marasas WF: Cytopathology of the oesophagus in Transkei. J Natl Cancer Inst 79: 961-967, 1987.
11. Sasaki K, Murakami T, Murakami T and Nakamura M: Intratumoral heterogeneity in DNA ploidy ofoesophageal squamous cell carcinomata. Cancer 68: 2403-2406, 1991.
12. Esrig D, Spruck C, Nichols PW, Chaiwun B, Steven K, Groshen S. Chen SC, Skinner DG, Jones PA and Cote RJ: P53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer Am J Pathol 143: 1389-1397, 1993.
13. Simony J, Pujol J, Radal M, Ursule E, Michel F and Pujol H: In situ evaluation of growth fraction determined by monoclonal antibody Ki67 and ploidy in surgically resected non-small cell lung cancers Cancer Res 50: 4382-4387, 1990.
14. Walker RA, Dearing SJ, Lane DP and Varley JM: Expression of p53 protein in infiltrating and in situ breast carcinomas. J Pathol 165. 203-211, 1991.
15. Sasano H, Miyazaki S, Gooukon Y, Nihihira T, Sawai T and Nagura H: Expression of p53 in human oesophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression. Hum Pathol 23: 1238-1243, 1992.
16. Wang LD, Lipkin M, Qui SL, Yang GR, Yang CS and Newmark HL: Labelling index and labeling distribution of cells inaesophageal epithelium of individuals at increased risk for oesophageal cancer in Huixian, China. Cancer Res 50: 2651-2653, 1990.
17. Dawsey SM, Wang GQ, Weinstein WM, Lewin KJ, Liu FS, Wiggett S, Nieberg RK, Li JY and Taylor PR: Squamous dysplasia and early esophageal cancer in the Linxian region of China: distinctive endoscopie lesions. Gastroenterology 105: 1333-1340, 1993.
18. Bacus S: An optical microscope image analysis system with clinical applications. American Clinical Product Review February: 26-31, 1988.
19. Danque POV, Chen HB, Patil J, Jagirdar J, Orsatti G and Paronetto F: Image analysis versus flow cytometry for DNA ploidy quantitation of solid tumours: A comparison of six methods of sample preparation. Modern Pathology 6: 270-275, 1993.
20. Lee AKC, Dugan J, Hamilton WM, Cook L, Heatly G, Kamat B and Silverman ML: Quantitative DNA analysis in breast carcinomas: comparison between image analysis and flow cytometry. Modern Pathology. 4: 178-182, 1991.
21. McCormick D, Chong H, Hobbs C, Datta C and Hall PA: Detection of the Ki∼67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 22: 355-360, 1993.
22. Goukon Y, Sasano H, Nihihira T, Nagura H and Mori S: p53 overexpression in humanoesophageal carcinoma: a correlation with tumour DNA and two-parameter flow cytometric study. Anticancer Res 14: 1305-1312, 1994.
23. Shi SR, Key ME and Kalra KL: Antigen retrieval in formalinfixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991.
24. Casson AG, Manolopoulos B, Troster M, Kerkvliet N, O'Malley F, Inculet R, Finley R and Roth JA: Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasiveoesophageal cancer. Am J Surg 167: 52-57, 1994.
25. Bourhis J, Bosq J, Wilson GD, Bressac B, Talbot M, Leridant AM, Dendale R, Janin N, Armand JP, Luboinski B, Malaise EP, Wibault P and Eschwege F: Correlation between p53 gene expression and tumour-cell proliferation in oropharyngeal cancer. Int J Cancer 57: 458-462, 1994.
26. Sasano H, Goukon Y, Nihihira T and Nagura H: In situ hybridisation and immunohistochemistry of p53 tumour suppressor gene in human oesophageal carcinoma. Am J Pathol 141: 545-550, 1992.
27. Shiao YH, Rugge M, Correa P, Lehmann HP and Scheer WD: P53 alteration in gastric precancerous lesions. Am J Pathol 144: 511-517, 1994.
28. Vahakangas KH, Samet JM, Metcalf RA, Welsh JA, Bennett WP, Lane DP and Harric CC: Mytations p53 and ras genes in radonassociated lung cancer from uranium miners Lancet 339: 576-580, 1992.
29. Shirasawa S, Urabe K, Yanagawa Y, Toshitani K, Iwama T and Sasazuki T: P53 gene mutations in colorectal tumors from patients with familial polyposis coli. Cancer Res 51: 2874-2878, 1991.
30. Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B and Roth JA: P53 gene mutations in Barrett's epithelium and oesophageal cancer. Cancer Res 51: 4495-4499, 1991.
31. Gusterson BA, Anbazhagan R, Warren W, Midgely C, Lane DP, O'Hare M, Stamps A, Carter R and Jayatilake H: Expression of p53 in premalignant and malignant squamous epithelium. Oncogene, 6: 1785-1789, 1991
32. Nuorva K, Soini Y, Kamel D, Autio-Harmainen H, Risteli L, Risteli J, Vahakangas K and Paakko P: Concurrent p53 expression in bronchial dysplasias and squamous cell carcinomas. Am J. Pathol 142: 725-732, 1993.
33. Jiko K, Sasano H, Ito K, Ozawa N, Sato S and Yajima A: Immunohistochemical and in situ hybridization analysis of p53 in human endometrial carcinoma of the uterus. Anticancer Res 13: 305-310, 1993.
34. Iggo R, Gatter K, Bartek J, Lane D and Harris AL: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335: 675-679, 1990.
35. Mayall FG, Goddard H and Gibbs AR: P53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections. J Pathol 168: 377-381, 1992.